Syngenta launches novel seed treatment insecticide
- Unrivalled early season broad spectrum insect control
- Powerful new grower tool for insect resistance management
- Registered in Argentina; multiple crops and countries pending
BASEL, Switzerland, Oct. 30, 2013 /PRNewswire/ -- Syngenta today announced the registration in Argentina of FORTENZA™, a novel seed treatment insecticide, for use on soybean, corn and sunflower. Further registrations are pending in multiple countries for both seed treatment and foliar uses across all major field crops. The global peak sales potential of the FORTENZA product family is expected to be around $300 million.
FORTENZA is based on the active ingredient (AI) cyantraniliprole, a second-generation diamide. It follows the 2008 launch of Syngenta's highly successful DURIVO™ product family, used in soil and foliar applications, and based on the AI chlorantraniliprole. FORTENZA was specifically developed as a seed treatment to control lepidoptera as well as chewing and sucking pests. FORTENZA Duo combines cyantraniliprole with thiamethoxam to set a new standard for early season pest control, while complementing the performance of insect resistant seed traits.
Syngenta Chief Operating Officer, John Atkin, said: "The FORTENZA product family will help give crops the best possible start by providing growers with powerful new tools against pests, above and below the ground. Data from more than 1,000 multi-year field trials demonstrate long-lasting protection and unrivalled yield benefits across multiple crops. This launch underpins our record of seed treatment innovation and our focus on efficient and low dose chemistry."
FORTENZA Duo will be available in Argentina for the current growing season.
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
Syngenta International AG
Tel: +41 61 323 2323
Fax: +41 61 323 2424
Switzerland +41 61 323 2323
USA + 1 202 737 8913
Switzerland +41 61 323 5059
USA +1 202 737 6521
Switzerland +41 61 323 6793
USA +1 202 737 6520
SOURCE Syngenta International AG